Tianda Pharmaceuticals Limited (HKG:0455)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0980
+0.0010 (1.03%)
Apr 28, 2026, 3:11 PM HKT
-45.56%
Market Cap 210.70M
Revenue (ttm) 322.95M
Net Income (ttm) -70.00M
Shares Out 2.15B
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 136,000
Average Volume 13,100
Open 0.0990
Previous Close 0.0970
Day's Range 0.0980 - 0.0990
52-Week Range 0.0890 - 0.2150
Beta -0.03
RSI 48.92
Earnings Date Aug 25, 2026

About Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. It operates through the Chinese Medicine, Pharmaceuticals and Medical Technologies, and Medical and Healthcare Services segments. The company offers Chinese herbal medicine, Chinese medicine decoction pieces, Chinese medicine products, and Chinese medicine clinical services. It also produces pharmaceutical products foc... [Read more]

Sector Healthcare
Founded 1992
Employees 613
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0455
Full Company Profile

Financial Performance

In 2025, Tianda Pharmaceuticals's revenue was 322.95 million, a decrease of -2.12% compared to the previous year's 329.94 million. Losses were -70.00 million, 14.1% more than in 2024.

Financial Statements

News

There is no news available yet.